ARCT CIK: 1768224

Arcturus Therapeutics Holdings Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−135
FY22:
32.0
FY23:
−18.1
FY24:
−59.7
FY25:
−74.3
Change from FY21 to FY25
millions USD
FY21:
−3.41
FY22:
−7.73
FY23:
−2.90
FY24:
−0.65
FY25:
−0.23
Change from FY21 to FY25
millions USD
FY21:
48.0
FY22:
−2.86
FY23:
−24.1
FY24:
5.42
FY25:
13.4
millions USD
FY21:
−90.4
FY22:
21.4
FY23:
−45.1
FY24:
−55.0
FY25:
−61.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−138
FY22:
24.3
FY23:
−21.0
FY24:
−60.4
FY25:
−74.5

All amounts in millions USD Data source:SEC EDGAR